Adverse drug reactions in tuberculosis and management
R Prasad, A Singh, N Gupta - Indian Journal of Tuberculosis, 2019 - Elsevier
Background Treatment of drug susceptible tuberculosis (DS-TB) requires regimens
containing first line drugs (FLDs') whereas drug resistant tuberculosis (DR-TB) are treated …
containing first line drugs (FLDs') whereas drug resistant tuberculosis (DR-TB) are treated …
Beyond the approved: target sites and inhibitors of bacterial RNA polymerase from bacteria and fungi
Covering: 2016 to 2022 RNA polymerase (RNAP) is the central enzyme in bacterial gene
expression representing an attractive and validated target for antibiotics. Two well-known …
expression representing an attractive and validated target for antibiotics. Two well-known …
Evaluation of risk factors for antituberculosis treatment induced hepatotoxicity
R Singla, SK Sharma, A Mohan… - Indian Journal of …, 2010 - journals.lww.com
Background & objectives: Antituberculosis (anti-TB) drug induced hepatotoxicity (DIH) is the
most common side effect leading to interruption of therapy. Wide variations have been found …
most common side effect leading to interruption of therapy. Wide variations have been found …
Incidence of antituberculosis-drug-induced hepatotoxicity and associated risk factors among tuberculosis patients in Dawro Zone, South Ethiopia: A cohort study
Background: Antituberculosis drugs cause hepatotoxicity in some individuals leading to
acute liver failure, which results in death. Such phenomena limit the clinical use of drugs …
acute liver failure, which results in death. Such phenomena limit the clinical use of drugs …
[HTML][HTML] First line anti-tuberculosis induced hepatotoxicity: incidence and risk factors
O El Bouazzi, S Hammi, JE Bourkadi… - The Pan African …, 2016 - ncbi.nlm.nih.gov
In our days, tuberculosis, whet ever its localization, became a curable disease. The
cornerstone is a 6 month course of isoniazid, rifampicine and pyrazinamide. All of the three …
cornerstone is a 6 month course of isoniazid, rifampicine and pyrazinamide. All of the three …
[HTML][HTML] Drug-induced liver injury from anti-tuberculosis treatment: a retrospective cohort study
H Zhao, Y Wang, T Zhang, Q Wang… - Medical science monitor …, 2020 - ncbi.nlm.nih.gov
Drug-Induced Liver Injury from Anti-Tuberculosis Treatment: A Retrospective Cohort Study -
PMC Back to Top Skip to main content NIH NLM Logo Access keys NCBI Homepage MyNCBI …
PMC Back to Top Skip to main content NIH NLM Logo Access keys NCBI Homepage MyNCBI …
Incidence and risk factors of antituberculosis drug-induced liver injury in India: A systematic review and meta-analysis
R Kumar, A Kumar, R Patel, SS Prakash… - Indian Journal of …, 2024 - Springer
Background Antituberculosis drug-induced liver injury (ATDILI) is a significant problem of
tuberculosis treatment. This systematic review and meta‑analysis aimed at evaluating the …
tuberculosis treatment. This systematic review and meta‑analysis aimed at evaluating the …
Risk of drug‐induced liver injury in chronic hepatitis B and tuberculosis co‐infection: A systematic review and meta‐analysis
C Chou, N Veracruz, AS Chitnis… - Journal of Viral …, 2022 - Wiley Online Library
Patients with tuberculosis (TB) disease treated with multi‐drug regimens are at risk of
developing drug induced liver injury (DILI), and DILI risk might be even higher in patients …
developing drug induced liver injury (DILI), and DILI risk might be even higher in patients …
[HTML][HTML] Prevalence of adverse drug reaction with first-line drugs among patients treated for pulmonary tuberculosis
A Singh, R Prasad, V Balasubramanian… - … epidemiology and global …, 2015 - Elsevier
Adverse drug reactions (ADRs) to first-line anti-tuberculosis drugs are common and may
cause associated morbidity and even mortality if not recognized early. 1, 2, 3 The overall …
cause associated morbidity and even mortality if not recognized early. 1, 2, 3 The overall …
Anti-tuberculosis therapy-induced hepatotoxicity among Ethiopian HIV-positive and negative patients
G Yimer, G Aderaye, W Amogne, E Makonnen… - PloS one, 2008 - journals.plos.org
Background To assess and compare the prevalence, severity and prognosis of anti-TB drug
induced hepatotoxicity (DIH) in HIV positive and HIV negative tuberculosis (TB) patients in …
induced hepatotoxicity (DIH) in HIV positive and HIV negative tuberculosis (TB) patients in …